DRA Rabbit Polyclonal Antibody
To Order Contact Us Below:
DRA Polyclonal Antibody |
|||
ES11294-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against DRA from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
DRA Polyclonal Antibody |
|||
ES4147-100ul | ELK Biotech | 100ul | EUR 334.8 |
Description: A Rabbit Polyclonal antibody against DRA from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
DRA Polyclonal Antibody |
|||
ES4147-50ul | ELK Biotech | 50ul | EUR 248.4 |
Description: A Rabbit Polyclonal antibody against DRA from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
DRA Polyclonal Antibody |
|||
ABP58418-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of DRA from Human. This DRA antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human DRA protein at amino acid sequence of 100-180 |
DRA Polyclonal Antibody |
|||
ABP58418-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of DRA from Human. This DRA antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human DRA protein at amino acid sequence of 100-180 |
DRA Polyclonal Antibody |
|||
ABP58418-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of DRA from Human. This DRA antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human DRA protein at amino acid sequence of 100-180 |
HLA-DRA Polyclonal Antibody |
|||
A71137-050 | EpiGentek | 50 ul | EUR 302.5 |
HLA-DRA Polyclonal Antibody |
|||
A71137-100 | EpiGentek | 100 ul | EUR 423.5 |
HLA-DRA Polyclonal Antibody |
|||
A71138-050 | EpiGentek | 50 ul | EUR 302.5 |
HLA-DRA Polyclonal Antibody |
|||
A71138-100 | EpiGentek | 100 ul | EUR 423.5 |
HLA-DRA Polyclonal Antibody |
|||
A53149-020 | EpiGentek | 20 ul | EUR 117.7 |
HLA-DRA Polyclonal Antibody |
|||
A53149-050 | EpiGentek | 50 ul | EUR 302.5 |
HLA-DRA Polyclonal Antibody |
|||
A53149-100 | EpiGentek | 100 ul | EUR 423.5 |
HLA-DRA Polyclonal Antibody |
|||
A53149 | EpiGentek |
|
|
HLA-DRA Polyclonal Antibody |
|||
A71137 | EpiGentek |
|
|
HLA-DRA Polyclonal Antibody |
|||
A71138 | EpiGentek |
|
|
HLA-DRA Rabbit pAb |
|||
A11787-100ul | Abclonal | 100 ul | EUR 369.6 |
HLA-DRA Rabbit pAb |
|||
A11787-200ul | Abclonal | 200 ul | EUR 550.8 |
HLA-DRA Rabbit pAb |
|||
A11787-20ul | Abclonal | 20 ul | EUR 219.6 |
HLA-DRA Rabbit pAb |
|||
A11787-50ul | Abclonal | 50 ul | EUR 267.6 |
HLA-DRA Rabbit pAb |
|||
A11790-100ul | Abclonal | 100 ul | EUR 369.6 |
HLA-DRA Rabbit pAb |
|||
A11790-200ul | Abclonal | 200 ul | EUR 550.8 |
HLA-DRA Rabbit pAb |
|||
A11790-20ul | Abclonal | 20 ul | EUR 219.6 |
HLA-DRA Rabbit pAb |
|||
A11790-50ul | Abclonal | 50 ul | EUR 267.6 |
HLA-DRA Rabbit pAb |
|||
A1579-100ul | Abclonal | 100 ul | EUR 369.6 |
HLA-DRA Rabbit pAb |
|||
A1579-200ul | Abclonal | 200 ul | EUR 550.8 |
HLA-DRA Rabbit pAb |
|||
A1579-20ul | Abclonal | 20 ul | EUR 219.6 |
HLA-DRA Rabbit pAb |
|||
A1579-50ul | Abclonal | 50 ul | EUR 267.6 |
HLA-DRA Rabbit mAb |
|||
A10863-100ul | Abclonal | 100 ul | EUR 492 |
HLA-DRA Rabbit mAb |
|||
A10863-200ul | Abclonal | 200 ul | EUR 685.2 |
HLA-DRA Rabbit mAb |
|||
A10863-20ul | Abclonal | 20 ul | EUR 265.2 |
HLA-DRA Rabbit mAb |
|||
A10863-50ul | Abclonal | 50 ul | EUR 344.4 |
HLA-DRA Antibody |
|||
1-CSB-PA17939A0Rb | Cusabio |
|
|
Description: A polyclonal antibody against HLA-DRA. Recognizes HLA-DRA from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
HLA-DRA Antibody |
|||
CSB-PA010497KA01HU-100ul | Cusabio | 100ul | EUR 466.8 |
Description: A polyclonal antibody against HLA-DRA. Recognizes HLA-DRA from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
HLA-DRA Antibody |
|||
DF6475 | Affbiotech | 200ul | EUR 420 |
HLA-DRA Antibody |
|||
32324-100ul | SAB | 100ul | EUR 302.4 |
HLA-DRA Antibody |
|||
20-abx125949 | Abbexa |
|
|
HLA- DRA Antibody |
|||
ABD6475 | Lifescience Market | 100 ug | EUR 525.6 |
HLA-DRA Antibody |
|||
abx233906-100ug | Abbexa | 100 ug | EUR 610.8 |
Anti-DRA Antibody |
|||
A03335 | BosterBio | 100ul | EUR 476.4 |
Description: Rabbit Polyclonal Antibody for DRA Antibody (SLC26A3) detection. Tested with WB in Human, Mouse, Rat. |
Anti-DRA antibody |
|||
STJ192452 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Unconjugated Rabbit polyclonal to DRA |
Anti-DRA antibody |
|||
STJ96782 | St John's Laboratory | 200 µl | EUR 236.4 |
Description: Rabbit polyclonal to DRA. |
HLA-DRA Antibody |
|||
CSB-PA010497KA01HU- | Cusabio | each | EUR 402 |
Description: A polyclonal antibody against HLA-DRA. Recognizes HLA-DRA from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200 |
Polyclonal HLA-DRA Antibody (N-term) |
|||
APR05804G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HLA-DRA (N-term). This antibody is tested and proven to work in the following applications: |
Polyclonal HLA-DRA Antibody (C-term) |
|||
APR05805G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HLA-DRA (C-term). This antibody is tested and proven to work in the following applications: |
HLA-DRA Polyclonal Antibody, Biotin Conjugated |
|||
A53146-050 | EpiGentek | 50 ul | EUR 302.5 |
HLA-DRA Polyclonal Antibody, Biotin Conjugated |
|||
A53146-100 | EpiGentek | 100 ul | EUR 423.5 |
HLA-DRA Polyclonal Antibody, FITC Conjugated |
|||
A53147-050 | EpiGentek | 50 ul | EUR 302.5 |
HLA-DRA Polyclonal Antibody, FITC Conjugated |
|||
A53147-100 | EpiGentek | 100 ul | EUR 423.5 |
HLA-DRA Polyclonal Antibody, HRP Conjugated |
|||
A53148-050 | EpiGentek | 50 ul | EUR 302.5 |
HLA-DRA Polyclonal Antibody, HRP Conjugated |
|||
A53148-100 | EpiGentek | 100 ul | EUR 423.5 |
HLA-DRA Polyclonal Antibody, Biotin Conjugated |
|||
A53146 | EpiGentek |
|
|
HLA-DRA Polyclonal Antibody, FITC Conjugated |
|||
A53147 | EpiGentek |
|
|
HLA-DRA Polyclonal Antibody, HRP Conjugated |
|||
A53148 | EpiGentek |
|
|
Anti-HLA-DRA/Hla Dr Rabbit Monoclonal Antibody |
|||
M01195-2 | BosterBio | 100ug/vial | EUR 476.4 |
Description: Rabbit Monoclonal HLA-DRA/Hla Dr Antibody. Validated in IF, WB and tested in Human, Mouse, Rat. |
HLA-DRA Conjugated Antibody |
|||
C32324 | SAB | 100ul | EUR 476.4 |
anti- HLA-DRA antibody |
|||
FNab03906 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against HLA-DRA |
HLA-DRA Antibody (HRP) |
|||
20-abx108373 | Abbexa |
|
|
HLA-DRA Antibody (Biotin) |
|||
20-abx105535 | Abbexa |
|
|
HLA-DRA Antibody (FITC) |
|||
20-abx106952 | Abbexa |
|
|
Anti-HLA-DRA antibody |
|||
PAab03906 | Lifescience Market | 100 ug | EUR 463.2 |
Anti-HLA-DRA antibody |
|||
STJ113370 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. |
Anti-HLA-DRA antibody |
|||
STJ113855 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. |
Anti-HLA-DRA antibody |
|||
STJ24027 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: HLA-DRA is one of the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. DRA does not have polymorphisms in the peptide binding part and acts as the sole alpha chain for DRB1, DRB3, DRB4 and DRB5. |
HLA-DRA siRNA |
|||
20-abx919567 | Abbexa |
|
|
HLA-DRA Antibody, HRP conjugated |
|||
1-CSB-PA17939B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against HLA-DRA. Recognizes HLA-DRA from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
HLA-DRA Antibody, FITC conjugated |
|||
1-CSB-PA17939C0Rb | Cusabio |
|
|
Description: A polyclonal antibody against HLA-DRA. Recognizes HLA-DRA from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
HLA-DRA Antibody, Biotin conjugated |
|||
1-CSB-PA17939D0Rb | Cusabio |
|
|
Description: A polyclonal antibody against HLA-DRA. Recognizes HLA-DRA from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Anti-MHC II DRA antibody |
|||
STJ16101043 | St John's Laboratory | 100 µg | EUR 424.8 |
HLA-DRA Antibody / HLA-DR |
|||
RQ5585 | NSJ Bioreagents | 100 ug | EUR 419 |
HLA-DRA Antibody (Clone # 302CT2.3.2) |
|||
6792-50 | Biovision | each | EUR 379.2 |
HLA-DRA Blocking Peptide |
|||
DF6475-BP | Affbiotech | 1mg | EUR 234 |
HLA-DRA cloning plasmid |
|||
CSB-CL360793HU1-10ug | Cusabio | 10ug | EUR 279.6 |
Description: A cloning plasmid for the HLA-DRA gene. |
HLA-DRA cloning plasmid |
|||
CSB-CL360793HU2-10ug | Cusabio | 10ug | EUR 279.6 |
Description: A cloning plasmid for the HLA-DRA gene. |
Dra I unit: 3500 |
|||
YRDRA1 | Yeastern Biotech | 1 vial | Ask for price |
Anti-HLA-DR/HLA-DRA Antibody |
|||
A01195 | BosterBio | 100ug/vial | EUR 400.8 |
Monoclonal HLA-DRA Antibody, Clone: 302CT2.3.2 |
|||
AMM02368G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A Monoclonal antibody against Human HLA-DRA. The antibodies are raised in Mouse and are from clone 302CT2.3.2. This antibody is applicable in WB, E |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNCA1082-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), APC conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNCA1090-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), APC conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNCA1096-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), APC conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNCAP1082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNCAP1082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNCAP1090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNCAP1090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNCAP1096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNCAP1096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC611082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF660R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC611082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF660R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC611090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF660R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC611090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF660R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC611096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF660R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC611096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF660R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNUM1082-50 | Biotium | 50uL | EUR 474 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), 1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNUM1090-50 | Biotium | 50uL | EUR 474 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), 1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNUM1096-50 | Biotium | 50uL | EUR 474 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), 1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNCR1082-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), RPE conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNCR1090-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), RPE conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNCR1096-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), RPE conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNUB1082-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), Concentration: 0.2mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNUB1082-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), Concentration: 0.2mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNUB1090-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), Concentration: 0.2mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNUB1090-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), Concentration: 0.2mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNUB1096-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), Concentration: 0.2mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNUB1096-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), Concentration: 0.2mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC431082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF543 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC431082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF543 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC431090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF543 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC431090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF543 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC431096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF543 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC431096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF543 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC051082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF405M conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC051082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF405M conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC051090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF405M conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC051090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF405M conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC051096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF405M conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC051096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF405M conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC401082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF640R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC401082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF640R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC401090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF640R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC401090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF640R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC401096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF640R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC401096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF640R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC811082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF680R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC811082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF680R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC811090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF680R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC811090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF680R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC811096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF680R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC811096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF680R conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC881082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF488A conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC881082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF488A conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC881090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF488A conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC881090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF488A conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC881096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF488A conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC881096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF488A conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC801082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF680 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC801082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF680 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC801090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF680 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC801090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF680 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC801096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF680 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC801096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF680 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNCH1082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNCH1082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNCH1090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNCH1090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNCH1096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNCH1096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNCP1082-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), PerCP conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNCP1090-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), PerCP conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNCP1096-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), PerCP conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC041082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF405S conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC041082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF405S conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC041090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF405S conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC041090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF405S conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC041096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF405S conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC041096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF405S conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC681082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF568 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC681082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF568 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC681090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF568 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC681090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF568 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC681096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF568 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC681096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF568 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC701082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF770 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC701082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF770 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC701090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF770 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC701090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF770 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC701096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF770 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC701096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF770 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNCB1082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), Biotin conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNCB1082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), Biotin conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNCB1090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), Biotin conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNCB1090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), Biotin conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNCB1096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), Biotin conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNCB1096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), Biotin conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC941082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF594 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC941082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF594 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC941090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF594 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC941090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF594 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC941096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF594 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC941096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF594 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC551082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF555 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC551082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF555 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC551090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF555 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC551090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF555 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC551096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF555 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC551096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF555 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC471082-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF647 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(19-26.1) Antibody |
|||
BNC471082-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(19-26.1), CF647 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC471090-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF647 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(IPO-10) Antibody |
|||
BNC471090-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(IPO-10), CF647 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC471096-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF647 conjugate, Concentration: 0.1mg/mL |
MHC II (HLA-DRA)(169-1B5.2) Antibody |
|||
BNC471096-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against MHC II (HLA-DRA)(169-1B5.2), CF647 conjugate, Concentration: 0.1mg/mL |
Monoclonal HLA-DRA Antibody (ascites), Clone: 302CT2.3.2 |
|||
AMM02367G | Leading Biology | 0.1 ml | EUR 580.8 |
Description: A Monoclonal antibody against Human HLA-DRA (ascites). The antibodies are raised in Mouse and are from clone 302CT2.3.2. This antibody is applicable in WB, E |
Anti-HLA-DRA (MHC II) Monoclonal Antibody |
|||
M01195-1 | BosterBio | 100ug/vial | EUR 476.4 |
Description: Mouse Monoclonal HLA-DRA (MHC II) Antibody. Validated in IHC and tested in Human. |
Human HLA-DRA shRNA Plasmid |
|||
20-abx952132 | Abbexa |
|
|
HLA-DRA protein (His tag) |
|||
80R-3720 | Fitzgerald | 100 ug | EUR 522 |
Description: Purified recombinant HLA-DRA protein (His tag) |
Human HLA-DRA ELISA KIT |
|||
ELI-32841h | Lifescience Market | 96 Tests | EUR 988.8 |
HLA-DRA ELISA KIT|Human |
|||
EF010147 | Lifescience Market | 96 Tests | EUR 826.8 |
HLA-DRA Recombinant Protein (Human) |
|||
RP014890 | ABM | 100 ug | Ask for price |
HLA-DRA Recombinant Protein (Human) |
|||
RP014893 | ABM | 100 ug | Ask for price |
HLA-DRA ELISA Kit (Human) (OKCA00694) |
|||
OKCA00694 | Aviva Systems Biology | 96 Wells | EUR 999.6 |
Description: Description of target: Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal microenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading. ;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 4.68 pg/mL |
HLA-DRA ORF Vector (Human) (pORF) |
|||
ORF004964 | ABM | 1.0 ug DNA | EUR 114 |
HLA-DRA ORF Vector (Human) (pORF) |
|||
ORF004965 | ABM | 1.0 ug DNA | EUR 114 |
Monoclonal HLA-DRA Antibody (Clone # 302CT2.3.2), Clone: Clone # 302CT2.3.2 |
|||
AMM00021G | Leading Biology | 0.05ml | EUR 580.8 |
Description: A Monoclonal antibody against Human HLA-DRA (Clone # 302CT2.3.2). The antibodies are raised in Mouse and are from clone Clone # 302CT2.3.2. This antibody is applicable in WB |
HLA-DRA sgRNA CRISPR Lentivector set (Human) |
|||
K0965101 | ABM | 3 x 1.0 ug | EUR 406.8 |
Human HLA-DRa Differentiation Reporter (pGreenZeo, Plasmid) |
|||
SR1007PA-1 | SBI | 10 ug | EUR 2098.8 |
Human HLA-DRa Differentiation Reporter (pGreenZeo, Virus) |
|||
SR1007VA-1 | SBI | >2 x 10^6 IFUs | EUR 906 |
Dra I-HC unit: 3500, High Concentration |
|||
YRDRA1-HC | Yeastern Biotech | 1 vial | Ask for price |
Met Rabbit Polyclonal Antibody |
|||
ABP57458-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of Met from Human, Mouse, Rat. This Met antibody is for IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein of Met of MET |
Met Rabbit Polyclonal Antibody |
|||
ABP57458-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of Met from Human, Mouse, Rat. This Met antibody is for IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein of Met of MET |
Met Rabbit Polyclonal Antibody |
|||
ABP57458-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of Met from Human, Mouse, Rat. This Met antibody is for IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein of Met of MET |
VEGF Rabbit Polyclonal Antibody |
|||
ABP57460-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of VEGF from Human, Mouse, Rat. This VEGF antibody is for IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein of VEGF of VEGFA |
VEGF Rabbit Polyclonal Antibody |
|||
ABP57460-01ml | Abbkine | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of VEGF from Human, Mouse, Rat. This VEGF antibody is for IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein of VEGF of VEGFA |
VEGF Rabbit Polyclonal Antibody |
|||
ABP57460-02ml | Abbkine | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of VEGF from Human, Mouse, Rat. This VEGF antibody is for IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein of VEGF of VEGFA |
CD10 Rabbit Polyclonal Antibody |
|||
ABP57461-003ml | Abbkine | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of CD10 from Human, Mouse, Rat. This CD10 antibody is for IHC-P. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen recombinant protein of CD10 of MME |